Tickers

1. Composite Trajectory Verdict

The income statement matters most for assessing XMTR's trajectory because the business is in a high-growth, loss-making phase where operating leverage and the path to GAAP profitability are the primary indicators of model viability, though cash flow and balance sheet sustainability are critical constraints.

Composite Trajectory: Mixed

Annual GAAP results show deteriorating bottom-line performance (net loss widened to $61.7M in FY2025 from $50.4M in FY2024) despite 26% revenue growth and improving operating leverage (operating loss narrowed to $45.5M from $56.1M). Quarterly results show sharply improving GAAP performance (Q2 2026 net loss of $5.3M vs $26.4M in Q2 2025) driven by strong revenue growth (41% YoY) and the absence of a $16.4M debt extinguishment loss. Annual operating cash flow turned positive ($6.1M in FY2025 vs -$15.4M in FY2024), but the cash balance fell to $15.0M at year-end 2025. The balance sheet weakened annually (equity fell to $275.6M from $314.5M, convertible debt rose to $327.5M from $283.6M) but was dramatically strengthened in Q2 2026 by $297.6M in equity proceeds.

2. Red Flags

• GAAP net loss widened annually despite 26% revenue growth: FY2025 net loss $61.7M vs FY2024 $50.4M (10-K FY2025, Consolidated Statements of Operations)
• Accumulated deficit increased 16.7% to $432.0M at Dec 31, 2025 from $370.3M at Dec 31, 2024 (10-K FY2025, Consolidated Balance Sheets)
• Cash and cash equivalents declined 32.5% to $15.0M at Dec 31, 2025 from $22.2M at Dec 31, 2024, before the Q2 2026 equity raise (10-K FY2025, Consolidated Statements of Cash Flows)
• $16.4M loss on debt extinguishment in FY2025 from partial repurchase of 2027 Notes (10-K FY2025, Consolidated Statements of Operations)
• Services revenue declined 4.4% to $57.0M in FY2025 from $59.6M in FY2024, continuing a multi-year downtrend from $68.7M in FY2023 (10-K FY2025, Consolidated Statements of Operations)
• Total gross margin compressed to 39.1% in FY2025 from 39.5% in FY2024 due to mix shift toward lower-margin marketplace revenue (10-K FY2025, MD&A)
• International segment remains Adjusted EBITDA negative: -$12.5M in FY2025 vs -$9.8M in FY2024 (10-K FY2025, Segment Note 12)
• Stock-based compensation rose to $36.4M (5.3% of revenue) in FY2025 from $29.3M (5.4% of revenue) in FY2024 (10-K FY2025, Non-GAAP Reconciliation)
• General and administrative expense as % of revenue increased in Q2 2026 to 10.8% from 10.4% in Q2 2025 (10-Q Q2 2026, MD&A)

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP results show a mixed picture: revenue grew 26% to $686.6M in FY2025 from $545.5M in FY2024, and operating loss narrowed to $45.5M (6.6% of revenue) from $56.1M (10.3% of revenue), reflecting operating leverage across all expense categories (10-K FY2025, Consolidated Statements of Operations). However, net loss widened to $61.7M from $50.4M due to a $16.4M loss on debt extinguishment and lower interest income (10-K FY2025, MD&A). Quarterly trends are strongly improving: Q2 2026 revenue surged 41% YoY to $229.3M, operating loss narrowed to $5.5M (2.4% of revenue) from $10.3M (6.3%), and net loss improved to $5.3M from $26.4M, partly due to the absence of the prior-year debt extinguishment loss (10-Q Q2 2026, Consolidated Statements of Operations). Marketplace gross margin improved to 34.7% in Q2 2026 from 35.4% in Q2 2025 (10-Q Q2 2026, MD&A). Six-month 2026 net loss of $10.6M compares favorably to $41.5M in the prior year period (10-Q Q2 2026, Consolidated Statements of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Annual operating cash flow turned positive in FY2025 at $6.1M after -$15.4M in FY2024 and -$29.9M in FY2023, driven by higher non-cash charges ($81.4M vs $50.5M) including $36.4M stock-based compensation and $16.4M debt extinguishment loss, partially offset by a $21.8M increase in accounts receivable (10-K FY2025, Consolidated Statements of Cash Flows). Investing cash outflows moderated to $16.6M in FY2025 from $20.2M in FY2024 (10-K FY2025, Consolidated Statements of Cash Flows). Financing activities provided $2.9M in FY2025, primarily from the $250M 2030 Notes issuance offset by $216.7M 2027 Notes repurchase, $17.5M capped calls, and $8.1M treasury stock purchase (10-K FY2025, Consolidated Statements of Cash Flows). The Q2 2026 equity raises (Siemens $50M and public offering ~$247.6M net) materially improved the liquidity position to $516.7M cash and marketable securities at June 30, 2026 (10-Q Q2 2026, Liquidity and Capital Resources), though detailed quarterly cash flow statements were truncated in the provided filing.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Annual comparison shows deterioration: total stockholders' equity fell 12.4% to $275.6M at Dec 31, 2025 from $314.5M at Dec 31, 2024, driven by the accumulated deficit increasing to $432.0M from $370.3M (10-K FY2025, Consolidated Balance Sheets). Convertible notes carrying value rose 15.5% to $327.5M from $283.6M due to the $250M 2030 Notes issuance partially offset by the $201.7M 2027 Notes repurchase (10-K FY2025, Note 11). Cash and marketable securities declined to $219.1M from $239.8M (10-K FY2025, Consolidated Balance Sheets). Current ratio remained healthy at 3.76x ($334.6M current assets vs $88.9M current liabilities) at Dec 31, 2025 (10-K FY2025, Consolidated Balance Sheets). The Q2 2026 equity issuances dramatically reversed these trends, bringing cash and marketable securities to $516.7M at June 30, 2026 (10-Q Q2 2026, Liquidity and Capital Resources), though the full June 30, 2026 balance sheet was not provided in the excerpts.

6. Data Gaps

• Complete quarterly cash flow statements for Q2 2026 and Q1 2026 (truncated in 10-Q Q2 2026 filing)
• Full balance sheet as of June 30, 2026 (only cash/marketable securities figure disclosed in MD&A)
• FY2023 full cash flow statement details (only three-year summary in 10-K)
• Quarterly revenue breakdown by segment for Q1 2026 (only Q2 and six-month provided)
• Quarterly Adjusted EBITDA by segment for Q1 2026
• Detailed accounts receivable aging and allowance methodology changes beyond the rollforward
• Capital expenditure breakdown between maintenance and growth for FY2025 and 2026 periods